Albumin Fluctuations Flag High Risk
Type 2 diabetes patients need close kidney monitoring beyond single albumin tests. urinary albumin-to-creatinine ratio (UACR) variability may predict mortality better than average levels alone. Doctors often see rising albumin but miss the pattern. This study shows how fluctuations drive outcomes. The study outcomes were published in Journal of Diabetes and its Complications.
Large Cohort Tracks Real-World Data
Researchers studied 3,536 T2DM patients in this retrospective cohort. They collected annual UACR data from index year plus two years prior. Standard deviation measured variability precisely. National Death Registry provided all-cause mortality endpoint reliably.
Long Follow-up Captures Event
Median follow-up lasted 49.3 months across the group. Total deaths reached 242 or 6.8% of patients during observation. Groups split by eGFR above or below 60 mL/min/1.73m2 for analysis.
Variability Worst in Both Kidney Groups
Patients with eGFR ≥60 showed highest mortality hazard ratio of 3.686 with 95% CI 2.116-6.421 in increased UACR plus high SD group. Normal UACR with low SD served as reference. eGFR below 60 patients hit HR 3.404 with 95% CI 1.361-8.511 in same high-risk category.
Synergy Drives Prediction Power
UACR elevation plus variability created synergistic mortality risk across kidney function levels. Stable normal UACR protected patients consistently. These patterns held after adjustments.
Test UACR Multiple Times Yearly
Annual measurements catch variability early in diabetes clinics. High SD plus rising levels demand aggressive intervention. Glycemic control and SGLT2 inhibitors may stabilize patterns.
Variability Beats Snapshots
Single high UACR readings mislead less than fluctuating ones. Track trends over years for true risk. Findings apply directly to daily T2DM management.
Stabilize Albumin to Save Lives
Reduce variability through multifactorial control. Kidney outcomes improve when UACR stays steady.